|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.04/0.42
|
企业价值
142.99M
|
资产负债 |
每股账面净值
-0.43
|
现金流量 |
现金流量率
--
|
损益表 |
收益
69.82M
|
每股收益
1.73
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/01/12 17:47 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States. |